Dabigatran etexilate Completed Phase 2 Trials for Heart Catheterization Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00818753Randomized, Open Label Study of Dabigatran Etexilate in Elective Percutaneous Coronary Intervention